Click on the session below to view the recorded video

Thursday, May 5

10:00 am – 10:05 am Welcome Remarks
10:05am – 10:50am Uterine Mesenchymal Tumors: What Does Ancillary Molecular Testing Add? – Dr. Teri Longacre, Stanford University, USA
10:50 am – 11:00am Question and Answer
11:00am – 11:45am Interest of multiplexed immunohistochemistry in thoracic pathology – Dr. Marius Ilié, University of Nice, France
11:45pm – 12:00pm Question and Answer
12:00pm – 12:15pm Coffee Break
12:15pm – 12:30pm Case Intro
12:30pm – 12:45pm Case 1: Vascular Tumor of the Liver: A Mimicker of Adenocarcinoma – Dr. ZuHua Gao, University of British Columbia, Canada
12:45pm – 1:00pm Case Discussion and Questions from the Audience
1:00pm – 1:45pm Practical PD-L1 Immunohistochemistry Assessment Moving from Tumor Proportion Score to Combined Positive Score – Dr. Pierre Fiset, McGill University, Canada
1:45pm – 2:00pm Question & Answer
2:00pm – 2:05pm Closing Remarks

 

Friday, May 6

10am – 10:05am Welcoming Remarks
10:05am – 11:45am Maximizing MMR Testing – From IHC to molecular stratification in GI and Gyne Tumours – Dr. David Schaeffer, University of British Columbia, Canada & Dr. Mary Kinloch, University of Saskatchewan, Canada
11:45am – 12:00pm Question and Answer
12:00pm – 12:15pm Coffee Break
12:15pm – 12:45pm Case 2: Perniosis mimicking T cell lymphoma in a pediatric patient – Dr. Gabriela Gheorghe, Saint Jude Children’s Research Hospital, USA
12:45pm – 1:00pm Case Discussion and Questions from the Audience
1:00pm – 1:45pm Metastatic Dedifferentiated Malignancies with Focus on Melanoma and the Value of Genotyping – Dr. Abbas Agaimy, University of Erlangen, Germany
1:45pm – 2:00pm Question and Answer
2:00pm – 2:05pm Closing Remarks